January 30, 2023
DIAGNOS Enters the Retinal Diagnostics Market With its New

BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS”, the “Company” or ”we”) (TSX Enterprise: ADK) (OTCQB: DGNOF) a frontrunner in early detection of crucial well being points by way of the usage of its FLAIRE platform based mostly on Synthetic Intelligence (AI), is proud to announce it’s getting into the fast-growing retinal diagnostics market, armed with its new 3D picture evaluation expertise.

DIAGNOS is pushing the boundaries of the follow with a deep learning-powered expertise able to diagnosing retinal situations equivalent to Age-Associated Macular Degeneration, Diabetic Retinopathy, Glaucoma, Macular Edema, Retinal Most cancers, and different retinal and macular illnesses. Furthermore, neurological and systemic illnesses affecting different components of the physique will also be recognized, together with Alzheimer’s illness, cardiovascular illnesses, a number of sclerosis, Parkinson’s illness, and so on.

The multimodal information evaluation instruments developed by DIAGNOS make the most of the newest developments in ophthalmic science. Combining information fetched from retinal photos and optical coherence tomography (OCT) scans, DIAGNOS makes use of probably the most correct applied sciences that exist for retinal diagnostics. The expertise is extra exact than MRI and ultrasound scanning, it’s non-invasive, and integrates the evaluation of 3D cross-sectional photos of the retina”.

“The rising curiosity for superior retinal imaging programs by the healthcare sector, the adoption of healthcare reimbursement insurance policies in a number of areas, and the evolution of the regulatory surroundings are among the components that made us take the choice to enter the retinal diagnostics market”, acknowledged Mr. Andre Larente, President of DIAGNOS. “Two of our most important rivals have just lately obtained investments of respectively $50M and $26M following their determination to enter the retinal diagnostics market, it definitely tells lots concerning the potential of this class”.

Technological developments in diagnostic strategies, quickly altering healthcare infrastructure, rising adoption of superior retinal imaging programs, and favorable healthcare reimbursement insurance policies contribute to the fast development of this class, as it’s anticipated to change into the gold customary of the long run within the profitable administration of retinal problems.

About DIAGNOS
DIAGNOS is a publicly traded Canadian company devoted to early detection of crucial well being issues based mostly on its FLAIRE Synthetic Intelligence (AI) platform. FLAIRE permits for fast modifying and creating of functions equivalent to CARA (Pc Assisted Retina Evaluation). CARA’s picture enhancement algorithms present sharper, clearer and easier-to-analyze retinal photos. CARA is an economical instrument for real-time screening of enormous volumes of sufferers. CARA has been cleared for commercialization by the next regulators: Well being Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).

Further data is offered at www.DIAGNOS.com and www.sedar.com

For additional data, please contact:

Mr. André Larente, President
DIAGNOS Inc.
Tel: 450 678-8882, ext. 224
Electronic mail: [email protected]

This information launch comprises forward-looking data. There might be no assurance that forward-looking data will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in these statements. DIAGNOS disclaims any intention or obligation to publicly replace or revise any forward-looking data, whether or not because of new data, future occasions or in any other case. The forward-looking data contained on this information launch is expressly certified by this cautionary assertion.

Neither the TSX Enterprise Alternate nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts duty for the adequacy or accuracy of this launch.

A photograph accompanying this announcement is offered at https://www.globenewswire.com/NewsRoom/AttachmentNg/d943a458-d0b6-43db-8cc4-39482d7f9b85

Leave a Reply